5-ホスホリボシル1α-二リン酸
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/12/03 23:13:03」(JST)
[Wiki en表示]
"PRPP" redirects here. It is not to be confused with Pooled Retirement Pension Plan.
|
This article does not cite any references (sources). Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
Phosphoribosyl pyrophosphate
|
Names |
Other names
5-phospho-alpha-D-ribose 1-diphosphate
|
Identifiers |
CAS Number
|
7540-64-9 N |
ChEBI |
CHEBI:17111 Y |
ChemSpider |
7062 Y |
DrugBank |
DB01632 Y |
InChI
-
InChI=1S/C5H13O14P3/c6-3-2(1-16-20(8,9)10)17-5(4(3)7)18-22(14,15)19-21(11,12)13/h2-7H,1H2,(H,14,15)(H2,8,9,10)(H2,11,12,13)/t2-,3-,4-,5-/m1/s1 Y
Key: PQGCEDQWHSBAJP-TXICZTDVSA-N Y
-
InChI=1/C5H13O14P3/c6-3-2(1-16-20(8,9)10)17-5(4(3)7)18-22(14,15)19-21(11,12)13/h2-7H,1H2,(H,14,15)(H2,8,9,10)(H2,11,12,13)/t2-,3-,4-,5-/m1/s1
Key: PQGCEDQWHSBAJP-TXICZTDVBW
|
Jmol interactive 3D |
Image |
MeSH |
Phosphoribosyl+pyrophosphate |
PubChem |
7339 |
SMILES
-
O=P(O[C@H]1O[C@@H]([C@@H](O)[C@H]1O)COP(=O)(O)O)(O)OP(=O)(O)O
|
Properties |
Chemical formula
|
C5H13O14P3 |
Molar mass |
390.07 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
N verify (what is YN ?) |
Infobox references |
|
|
Phosphoribosyl pyrophosphate (PRPP) is a pentosephosphate.
It is formed from ribose 5-phosphate by the enzyme ribose-phosphate diphosphokinase.
It plays a role in transferring phospho-ribose groups in several reactions:
Enzyme |
Reactant |
Product |
adenine phosphoribosyltransferase |
adenine |
AMP |
hypoxanthine-guanine phosphoribosyltransferase |
guanine |
GMP |
hypoxanthine-guanine phosphoribosyltransferase |
hypoxanthine |
IMP |
orotate phosphoribosyltransferase |
orotate |
OMP |
uracil phosphoribosyltransferase |
uracil |
UMP |
In de novo generation of purines, the enzyme amidophosphoribosyltransferase acts upon PRPP to create phosphoribosylamine.
Increased PRPP
Increased levels of PRPP is characterized by the overproduction and accumulation of uric acid leading to hyperuricemia and hyperuricosuria. It is one of the causes of gout.
Increased levels of PRPP are present in Lesch-Nyhan Syndrome. Decreased levels of hypoxanthine guanine phosphoribosyl transferase (HGPRT) causes this accumulation, as PRPP is a substrate used by HGPRT during purine salvage.
See also
Nucleotide metabolic intermediates
|
|
Purine metabolism |
Anabolism |
R5P→IMP: |
- R5P
- PRPP
- PRA
- GAR
- FGAR
- FGAM
- AIR
- CAIR
- SAICAR
- AICAR
- FAICAR
|
|
IMP→AMP: |
|
|
IMP→GMP: |
|
|
|
Catabolism |
- Hypoxanthine
- Xanthine
- Uric acid
- 5-Hydroxyisourate
|
|
|
Pyrimidine metabolism |
Anabolism |
- Carbamoyl phosphate
- Carbamoyl aspartic acid
- 4,5-Dihydroorotic acid
- Orotic acid
- Orotidine 5'-monophosphate
- Uridine monophosphate
|
|
Catabolism |
uracil: |
- Dihydrouracil
- 3-Ureidopropionic acid
- β-Alanine
|
|
thymine: |
- Dihydrothymine
- β-Ureidoisobutyric acid
- 3-Aminoisobutyric acid
|
|
|
|
Index of inborn errors of metabolism
|
|
Description |
- Metabolism
- Enzymes and pathways: citric acid cycle
- pentose phosphate
- glycoproteins
- glycosaminoglycans
- phospholipid
- cholesterol and steroid
- sphingolipids
- eicosanoids
- amino acid
- urea cycle
- nucleotide
|
|
Disorders |
- Citric acid cycle and electron transport chain
- Glycoprotein
- Proteoglycan
- Fatty-acid
- Phospholipid
- Cholesterol and steroid
- Eicosanoid
- Amino acid
- Purine-pyrimidine
- Heme metabolism
- Symptoms and signs
|
|
Treatment |
|
Index of biochemical families
|
|
Carbohydrates |
- Alcohols
- Glycoproteins
- Glycosides
|
|
Lipids |
- Eicosanoids
- Fatty acids
- Glycerides
- Phospholipids
- Sphingolipids
- Steroids
|
|
Nucleic acids |
|
|
Proteins |
|
|
Other |
|
|
|
English Journal
- Mutations in PRPS1 causing syndromic or nonsyndromic hearing impairment: intrafamilial phenotypic variation complicates genetic counseling.
- Gandía M1, Fernández-Toral J2, Solanellas J3, Domínguez-Ruiz M1, Gómez-Rosas E1, Del Castillo FJ1, Villamar M1, Moreno-Pelayo MA1, Del Castillo I1.
- Pediatric research.Pediatr Res.2015 Mar 18. doi: 10.1038/pr.2015.56. [Epub ahead of print]
- BACKGROUND: PRPS1 encodes isoform I of phosphoribosylpyrophosphate synthetase (PRS-I), a key enzyme in nucleotide biosynthesis. Different missense mutations in PRPS1 cause a variety of disorders that include PRS-I superactivity, nonsyndromic sensorineural hearing impairment, Charcot-Marie-Tooth dise
- PMID 25785835
- Purinosome formation as a function of the cell cycle.
- Chan CY1, Zhao H2, Pugh RJ2, Pedley AM2, French J3, Jones SA4, Zhuang X5, Jinnah H6, Huang TJ1, Benkovic SJ7.
- Proceedings of the National Academy of Sciences of the United States of America.Proc Natl Acad Sci U S A.2015 Feb 3;112(5):1368-73. doi: 10.1073/pnas.1423009112. Epub 2015 Jan 20.
- The de novo purine biosynthetic pathway relies on six enzymes to catalyze the conversion of phosphoribosylpyrophosphate to inosine 5'-monophosphate. Under purine-depleted conditions, these enzymes form a multienzyme complex known as the purinosome. Previous studies have revealed the spatial organiza
- PMID 25605889
- Novel C12orf65 mutations in patients with axonal neuropathy and optic atrophy.
- Tucci A1, Liu YT, Preza E, Pitceathly RD, Chalasani A, Plagnol V, Land JM, Trabzuni D, Ryten M; UKBEC, Jaunmuktane Z, Reilly MM, Brandner S, Hargreaves I, Hardy J, Singleton AB, Abramov AY, Houlden H.
- Journal of neurology, neurosurgery, and psychiatry.J Neurol Neurosurg Psychiatry.2014 May;85(5):486-92. doi: 10.1136/jnnp-2013-306387. Epub 2013 Nov 6.
- OBJECTIVE: Charcot-Marie Tooth disease (CMT) forms a clinically and genetically heterogeneous group of disorders. Although a number of disease genes have been identified for CMT, the gene discovery for some complex form of CMT has lagged behind. The association of neuropathy and optic atrophy (also
- PMID 24198383
Japanese Journal
- Effect of Amplification of Desensitized purF and prs on Inosine Accumulation in Escherichia coli(MICROBIAL PHYSIOLOGY AND BIOTECHNOLOGY)
- Journal of bioscience and bioengineering 103(3), 255-261, 2007-03-25
- NAID 110006271247
- Effect of Amplification of Desensitized purF and prs on Inosine Accumulation in Escherichia coli
- Amidophosphoribosyltransferase(ATase) と Phosphoribosylpyrophosphate (PRPP) 合成酵素遺伝子多型と産生過剰型痛風の関連解析
- 痛風と核酸代謝 = Gout and nucleic acid metabolism 30(1), 79, 2006-07-01
- NAID 10017657087
Related Links
- El término Phosphoribosylpyrophosphate figura en la edición en idioma inglés de Wikipedia. Allí se dice al respecto lo siguiente: Phosphoribosyl pyrophosphate (PRPP) is a pentosephosphate. It is formed from ribose 5-phosphate by ...
- Structure, classification, information, physical and chemical properties for PRPP, PRib-PP, Alpha-Phosphoribosylpyrophosphoric Acid, 5-Phosphoribosyl diphosphate, 5-Phospho-alpha-D-ribose 1-diphosphate ... Show subcontent ...
Related Pictures
★リンクテーブル★
[★]
- 英
- 6-mercaptopurine, mercaptopunne
- ラ
- 6-mercaptopurinum
- 同
- 6-MP
- 商
- ロイケリン
- 関
- アザチオプリン、制癌薬
- GOO. 134-138,1347f
- プリン代謝拮抗薬
- 抗悪性腫瘍薬
代謝
作用機序
- 本剤は、細胞増殖に重要な意義をもつ核酸の生合成を阻害する。メルカプトプリンは細胞内でinosinic acidのチオ同族体 thioinosinic acid(TIMP)に変換し、このTIMPは主としてinosinic acid からのadenylosuccinic acid 及びxanthylic acidへの転換を阻害し、adenine, guanineribonucleotideの生合成を阻害するとされている
適応
- 白血病、悪性リンパ腫以外の腫瘍に対しては効果が少なく適応されない
注意
重大な副作用
添付文書
- http://www.info.pmda.go.jp/go/pack/4221001B1052_1_02/4221001B1052_1_02?view=body
[★]
- 英
- phosphoribosylpyrophosphate,5-phosphoribosyl 1-pyrophosphate ,PRPP
- 同
- 5-ホスホリボシル1-ピロリン酸、ホスホリボシルピロリン酸 phosphoribosyl pyrophosphate、5-ホスホリボシル1-二リン酸 5-phosphoribosyl 1-diphosphate
[★]
- 同
- phosphoribosylpyrophosphate
[★]
- 同
- phosphoribosylpyrophosphate